Sebastian Hymson

Company: BioNTech AG

Job title: Scientist

Seminars:

Matrix-based Approach to Potency Assay Development for Adoptive T Cell Therapies 12:00 pm

• Developing phase-appropriate T cell potency assays, balancing critical quality attributes and available technologies • Leveraging compliant characterization technologies to gain a well-rounded understanding of T cell functionality • Establishing a potency assay matrix, maximizing correlation to clinical efficacy while minimizing late-phase riskRead more

day: Conference Day One - Track A - AM